We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+2.57%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$70.1B
AUM Growth
-$3.23B
Cap. Flow
-$4.59B
Cap. Flow %
-6.55%
Top 10 Hldgs %
10.04%
Holding
5,020
New
596
Increased
1,359
Reduced
1,925
Closed
795

Sector Composition

Rank Sector Weight
1 Communication Services 9.11%
2 Healthcare 7.95%
3 Consumer Discretionary 7.93%
4 Financials 7.4%
5 Technology 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELNK
4176
DELISTED
EarthLink Holdings Corp.
ELNK
$51K ﹤0.01%
14,158
-197,849
-93% -$846K
PGNX
4177
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$48K ﹤0.01%
11,689
-395,074
-97% -$2.02M
STAB
4178
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$46K ﹤0.01%
3,352
-215
-6% -$3.5K
WTSL
4179
DELISTED
WET SEAL INC CL-A
WTSL
$45K ﹤0.01%
34,341
-53,681
-61% -$110K
CTIC
4180
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$42K ﹤0.01%
1,237
-41,509
-97% -$1.42M
VRNG
4181
DELISTED
VRINGO, INC COM STK NEW (DE)
VRNG
$41K ﹤0.01%
1,180
-2,235
-65% -$84.3K
ENZN
4182
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$40K ﹤0.01%
39,311
ATLC icon
4183
Atlanticus Holdings
ATLC
$1.5B
$37K ﹤0.01%
16,155
RSH
4184
DELISTED
RADIOSHACK CORP
RSH
$34K ﹤0.01%
15,891
-15,075
-49% -$35.4K
CERE
4185
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$33K ﹤0.01%
4,761
+1,590
+50% +$16.6K
NIHD
4186
DELISTED
NII HOLDINGS INC CL B
NIHD
$31K ﹤0.01%
25,782
-112,214
-81% -$248K
GMO
4187
DELISTED
General Moly, Inc.
GMO
$30K ﹤0.01%
29,900
-96,538
-76% -$117K
MBOT icon
4188
Microbot Medical
MBOT
$115M
$29K ﹤0.01%
13
-12
-48% -$28.7K
DVR
4189
DELISTED
CAL DIVE INTERNATIONAL INC COM
DVR
$25K ﹤0.01%
14,758
-1,700
-10% -$3.01K
VIEW
4190
DELISTED
VIEWTRAN GROUP INC, ORD SHS
VIEW
$24K ﹤0.01%
10,300
GNK
4191
DELISTED
GENCO SHIPPING & TRADING LTD
GNK
$22K ﹤0.01%
12,691
-34,514
-73% -$65.9K
LFVN icon
4192
LifeVantage
LFVN
$82.4M
$21K ﹤0.01%
2,264
-114
-5% -$1.14K
LDK
4193
DELISTED
LDK SOLAR CO LTD.
LDK
$20K ﹤0.01%
78,198
-51,787
-40% -$60.5K
ACUR
4194
DELISTED
Acura Pharmaceuticals
ACUR
$17K ﹤0.01%
+2,311
New +$20.1K
KIOR
4195
DELISTED
KIOR, INC CLASS A COM STK
KIOR
$12K ﹤0.01%
20,661
+8,511
+70% +$10.3K
SWSH
4196
DELISTED
SWISHER HYGIENE INC COM STK NEW (DE)
SWSH
$11K ﹤0.01%
2,435
-7,376
-75% -$38.1K
CYHHZ
4197
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$9K ﹤0.01%
+151,400
New +$8.4K
DCTH
4198
DELISTED
Delcath Systems Inc
DCTH
$6K ﹤0.01%
82
-204
-71% -$16.5K
LLEN
4199
DELISTED
L & L ENERGY INC COM STK (NV)
LLEN
$5K ﹤0.01%
15,363
ABM icon
4200
ABM Industries
ABM
$2.8B
-12,130
Closed -$347K

Similar funds

D.E. Shaw & Co's Q1 2014 Portfolio in Review

As of Q1 2014, D.E. Shaw & Co held 5,020 positions worth $70.1B, down 4.4% from $73.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

D.E. Shaw & Co withdrew a net $4.59B in Q1 2014, closing 795 positions and reducing 1,925 holdings. Its most notable exit was LIFE TECHNOLOGIES CORP COM STK (DE), an estimated $236M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 9.1% of assets, up from 6.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, D.E. Shaw & Co opened a new position in Veren worth $53.3M.

  • D.E. Shaw & Co's largest Q1 2014 buy was Veren: 1,596,878 shares worth $53.3M.
  • D.E. Shaw & Co added most to Liberty Global Class C in Q1 2014, an estimated $404M increase.
  • D.E. Shaw & Co's biggest Q1 2014 reduction was Apple, cutting an estimated $453M.
  • D.E. Shaw & Co fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $236M.
  • D.E. Shaw & Co's ten largest holdings make up 10% of its $70.1B portfolio in Q1 2014.
  • D.E. Shaw & Co opened 596 new positions and closed 795 in Q1 2014.
  • D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $70.1B.

Based on D.E. Shaw & Co's 13F filing for Q1 2014, filed 15 May 2014.